Book Appointment
Book Appointment

Blogs and Resources

PGT-A in IVF: Understanding Genetic Embryo Screening

Blog image

PGT-A in IVF: Understanding Genetic Embryo Screening

Introduction

IVF treatment has advanced significantly over the years, improving the chances of achieving a healthy pregnancy. One of the most important advancements in modern fertility care is PGT-A (Preimplantation Genetic Testing for Aneuploidy).

PGT-A helps fertility specialists identify embryos with the correct number of chromosomes before embryo transfer, improving embryo selection and reducing certain pregnancy risks.

This blog explains:

  • What PGT-A is

  • How it works

  • Who may benefit from it

  • Its advantages and limitations

What Is PGT-A?

PGT-A is a genetic screening test performed during an IVF cycle to evaluate embryos for chromosomal abnormalities.

A normal embryo typically contains:

  • 46 chromosomes

  • 23 from the egg

  • 23 from the sperm

When embryos have missing or extra chromosomes, implantation may fail or miscarriage risk may increase.

PGT-A helps identify embryos that are more likely to result in a healthy pregnancy.

What Does “Aneuploidy” Mean?

Aneuploidy refers to an abnormal number of chromosomes.

Examples include:

  • Missing chromosomes

  • Extra chromosomes

  • Chromosomal imbalance

These abnormalities can affect:

  • Implantation success

  • Pregnancy progression

  • Embryo development

How PGT-A Works in IVF

Step 1: IVF & Embryo Development

Eggs are retrieved and fertilized in the laboratory.

Embryos are allowed to grow for about:

  • 5 to 6 days (blastocyst stage)

Step 2: Embryo Biopsy

A few cells are carefully removed from the outer layer of the embryo.

This procedure does not usually harm embryo development when performed correctly.

Step 3: Genetic Testing

The biopsied cells are analyzed in a genetics laboratory to evaluate chromosome numbers.

Embryos are categorized as:

  • Chromosomally normal (euploid)

  • Chromosomally abnormal (aneuploid)

  • Mosaic (mixed cell population)

Step 4: Embryo Freezing

Embryos are frozen while waiting for results.

Step 5: Embryo Transfer

The healthiest chromosomally normal embryo is selected for transfer.

Who May Benefit from PGT-A?

PGT-A is not necessary for every patient, but it may be recommended in certain situations.

Common indications include:

Advanced Maternal Age

Egg quality and chromosomal abnormalities increase with age.

Recurrent IVF Failure

Repeated failed implantation may sometimes be related to embryo chromosomal issues.

Recurrent Miscarriages

PGT-A may help reduce miscarriage risk associated with abnormal embryos.

Severe Male Factor Infertility

Some sperm abnormalities may affect embryo quality.

Multiple Embryos Available

PGT-A helps identify the most viable embryo for transfer.

Benefits of PGT-A

Improved Embryo Selection

Helps choose embryos with higher implantation potential.

Reduced Risk of Miscarriage

Chromosomal abnormalities are one of the most common causes of miscarriage.

Better Pregnancy Planning

Supports more informed treatment decisions.

Potentially Shorter Time to Pregnancy

Selecting healthier embryos may reduce unsuccessful transfer attempts.

Supports Single Embryo Transfer

Can reduce the need for multiple embryo transfers.

Does PGT-A Guarantee Pregnancy?

No.

PGT-A improves embryo selection, but pregnancy success still depends on:

  • Uterine health

  • Hormonal balance

  • Implantation factors

  • Overall reproductive health

Even a genetically normal embryo may not always implant successfully.

Limitations of PGT-A

Not All Embryos Reach Testing Stage

Some embryos may stop developing before biopsy.

Additional Cost

PGT-A increases IVF treatment expenses.

Mosaic Embryos Can Be Complex

Some embryos show mixed normal and abnormal cells, making decisions more nuanced.

No Test Is 100% Perfect

PGT-A significantly improves screening, but cannot guarantee outcomes.

Is PGT-A Safe?

PGT-A is generally considered safe when performed by experienced embryologists using modern IVF laboratory techniques.

Most clinics perform the biopsy at the blastocyst stage, which minimizes risk to embryo development.

PGT-A and Age

PGT-A is more commonly recommended for women above 35 because chromosomal abnormalities tend to increase with age.

However, younger patients with:

  • recurrent miscarriage

  • repeated IVF failure

  • genetic concerns

may also benefit.

Frozen Embryo Transfer After PGT-A

Because embryos are frozen after biopsy, PGT-A cycles are usually followed by a Frozen Embryo Transfer (FET).

This allows:

  • Better uterine preparation

  • Time for genetic analysis

  • Improved treatment planning

Emotional Considerations

PGT-A can provide reassurance for some couples, but it can also feel emotionally overwhelming.

Patients may experience:

  • Anxiety while waiting for results

  • Disappointment if few embryos are normal

  • Confusion regarding mosaic embryos

Supportive fertility counseling and clear communication are important throughout the process.

Questions to Ask Your Fertility Specialist

Before choosing PGT-A, ask:

  • Is PGT-A recommended in my case?

  • What are the benefits for my situation?

  • How many embryos are expected?

  • What are the costs involved?

  • How are mosaic embryos handled?

Conclusion

PGT-A is one of the most important advancements in modern IVF treatment. By helping identify chromosomally healthy embryos, it can improve embryo selection and support better-informed fertility decisions.

However, PGT-A is not necessary for everyone. The best approach depends on your:

  • age

  • fertility history

  • medical condition

  • treatment goals

A personalized discussion with your fertility specialist can help determine whether PGT-A is the right step in your IVF journey